Cargando…

Practice patterns for antibiotic de-escalation in culture-negative healthcare-associated pneumonia

BACKGROUND: Published guidelines for the treatment of healthcare-associated pneumonia (HCAP) recommend initial broad-spectrum antibiotics with appropriate de-escalation based on culture results. Guideline recommendations are based on data from intubated patients, in whom cultures are easily obtained...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schlueter, M., James, C., Dominguez, A., Tsu, L., Seymann, G.
Formato:	Texto
Lenguaje:	English
Publicado:	Urban and Vogel 2010
Materias:	Clinical and Epidemiological Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945711/ https://www.ncbi.nlm.nih.gov/pubmed/20652354 http://dx.doi.org/10.1007/s15010-010-0042-z

Ejemplares similares

De-escalation of Broad Spectrum Antibiotics Following Negative Cultures in Pneumonia: Rates and Outcomes
por: Deshpande, Abhishek, et al.
Publicado: (2017)

Safety of antimicrobial de-escalation for culture-negative severe pneumonia
por: Byoung Soo, Kwon, et al.
Publicado: (2019)

1471. Evaluation of Antibiotic De-escalation in Post Cardiac Arrest Patients with Culture-Negative versus Culture-Positive Aspiration Pneumonia
por: Herzig, Natasha R, et al.
Publicado: (2020)

Antibiotic De-Escalation in Critically Ill Patients with Negative Clinical Cultures
por: Roper, Spencer, et al.
Publicado: (2023)

PCR-Based Serotyping of Streptococcus pneumoniae from Culture-Negative Specimens: Novel Primers for Detection of Serotypes within Serogroup 18
por: Tanmoy, Arif M., et al.
Publicado: (2016)

Antibiotic prescribing on admission to patients with pneumonia and prior outpatient antibiotic treatment: a cohort study on clinical outcome
por: van de Garde, Ewoudt M W, et al.
Publicado: (2015)

Different Effects of Antibiotics on Klebsiella pneumoniae and Escherichia coli Resistance Induced by Antibiotics: A Retrospective Study from China
por: Chen, Jing, et al.
Publicado: (2022)

Impact of SARS on Avian Influenza Preparedness in Healthcare Workers
por: Tam, D. K. P., et al.
Publicado: (2007)

Safety and feasibility of antibiotic de-escalation in bacteremic pneumonia
por: Khasawneh, Faisal A, et al.
Publicado: (2014)

Risk factors and clinical significance of invasive infections caused by levofloxacin-resistant Streptococcus pneumoniae
por: Isea-Peña, M. C., et al.
Publicado: (2013)

Diagnostic and Prognostic Values of Admission Procalcitonin Levels in Community–Acquired Pneumonia in an Intensive Care Unit
por: Boussekey, N., et al.
Publicado: (2005)

Escalating Coverage of Obesity in UK Newspapers: The Evolution and Framing of the “Obesity Epidemic” From 1996 to 2010
por: Hilton, Shona, et al.
Publicado: (2012)

Patterns of recurring dispensing of guideline antibiotics for uncomplicated urinary tract infection in women over a 5-year period: Longitudinal patterns of recurring dispensings of Dutch guideline UTI antibiotics
por: Lelie- van der Zande, Rian C, et al.
Publicado: (2020)

The potential of molecular diagnostics and serum procalcitonin levels to change the antibiotic management of community-acquired pneumonia
por: Gilbert, David, et al.
Publicado: (2016)

Knowledge, attitude and practice of antibiotics and their determinants in Eritrea: an urban population-based survey
por: Russom, Mulugeta, et al.
Publicado: (2021)

Switching and Escalating Therapy in Long-Lasting Multiple Sclerosis: Not Always Necessary
por: Carvalho, Ana Teresa, et al.
Publicado: (2012)

The impact of antimicrobial de-escalation therapy in culture-negative pneumonia: a systematic review and meta-analysis
por: Song, Jae-Uk, et al.
Publicado: (2023)

A multiplex polymerase chain reaction assay for antibiotic stewardship in suspected pneumonia()()()
por: Pickens, Chiagozie, et al.
Publicado: (2020)

Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritis
por: Takeuchi, Tsutomu, et al.
Publicado: (2011)

Reporting Emerging Resistance of Streptococcus pneumoniae from India
por: Chawla, Kiran, et al.
Publicado: (2010)

A dose escalation trial for the combination of erlotinib and sirolimus for recurrent malignant gliomas
por: Nghiemphu, Phioanh Leia, et al.
Publicado: (2012)

Demographic and socioeconomic patterns in healthcare-seeking behaviour for respiratory symptoms in England: a comparison with non-respiratory symptoms and between three healthcare services
por: Morrison, Kirsty E, et al.
Publicado: (2020)

Dose-Escalated Hypofractionated Intensity-Modulated Radiotherapy in High-Risk Carcinoma of the Prostate: Outcome and Late Toxicity
por: Thomson, David, et al.
Publicado: (2012)

3488 A comparison between the Rolling 6 and 3+3 dose escalation study designs for phase 1 clinical trials
por: Minard, Charles Gene, et al.
Publicado: (2019)

A dose-escalation study of indisulam in combination with capecitabine (Xeloda) in patients with solid tumours
por: Siegel-Lakhai, W S, et al.
Publicado: (2008)

A phase I dose-escalation study of eribulin and S-1 for metastatic breast cancer
por: Sakiyama, T, et al.
Publicado: (2015)

Symptom reporting, healthcare-seeking behaviour and antibiotic use for common infections: protocol for Bug Watch, a prospective community cohort study
por: Smith, Catherine M, et al.
Publicado: (2019)

76865 Clinical Outcomes of Chronic Myelomonocytic Leukemia in the VA Healthcare System
por: Achar, Rohan, et al.
Publicado: (2021)

Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group
por: Svicher, V., et al.
Publicado: (2013)

Low gonorrhoea antimicrobial resistance and culture positivity rates in general practice: a pilot study
por: Visser, Maartje, et al.
Publicado: (2020)

Cross-Cultural Patterns in College Student Drinking and its Consequences—A Comparison between the USA and Sweden
por: Ståhlbrandt, Henriettæ, et al.
Publicado: (2008)

Gram-negative bacteria isolates and their antibiotic-resistance patterns among pediatrics patients in Ethiopia: A systematic review
por: Kebede, Bekalu, et al.
Publicado: (2022)

Lack of pathogen identification influencing antibiotic de-escalation in hospital-acquired pneumonia
por: Bittmann, Matthew C., et al.
Publicado: (2022)

Phase I dose escalation study of telatinib (BAY 57-9352) in patients with advanced solid tumours
por: Strumberg, D, et al.
Publicado: (2008)

Phase I dose-escalation study of aflibercept in combination with docetaxel and cisplatin in patients with advanced solid tumours
por: Freyer, G, et al.
Publicado: (2012)

Dose escalation to rash for erlotinib plus gemcitabine for metastatic pancreatic cancer: the phase II RACHEL study
por: Van Cutsem, E, et al.
Publicado: (2014)

Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still’s disease
por: Gabay, Cem, et al.
Publicado: (2018)

Treatment Strategy and Outcomes in Patients with Hematogenous Culture-Negative Pyogenic Vertebral Osteomyelitis
por: Mohamad, Gouse, et al.
Publicado: (2019)

Patterns of Antibiotic Resistance Among Group B Streptococcus Isolates: 2001–2004
por: Chohan, Lubna, et al.
Publicado: (2006)

10351 Antibiotic Use for Respiratory Syncytial Virus in the Middle East: A Surveillance Study in Hospitalized Jordanian Children
por: Rankin, Danielle A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_miaaissb9e26l502is7rcousqf